As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
Despite this, many rare disease trials continue to rely on a single outcome to assess efficacy and determine success or failure. While multiple outcomes are collected, they typically play limited or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results